Oral Delivery of Large Molecules
Oral Delivery of Large Molecules
Home
About Us
Company Profile
Strategy
Management Team
Board of Directors
Technology
Oral Drug Delivery
Parathyroid Hormone
Supportive Publications
Pipeline
Progress Summary
Osteoporosis
Hypoparathyroidism
Bone Healing
News and Events
News
Events
Investors
Contact Us
Oral Delivery of Large Molecules
Sitemap
Main Menu
Home
About Us
Strategy
Management Team
Dr. Hillel Galitzer – COO
Dr. Arthur Santora - CMO
Dana Yaacov-Garbeli - CFO
Miranda Toledano - CEO
Board of Directors
Mr. Ron Mayron
Dr. Roger Garceau
Mr. Gerald Lieberman - Chairman of the Board
Mr. Yonatan Malca
Miranda J. Toledano - CEO
Mr. Gerald M. Ostrov
Technology
Parathyroid Hormone
Pipeline
Osteoporosis
Overview
Market
Current Status
Hypoparathyroidism
Overview
Market
Current Status
Bone Healing
Overview
Market
Current Status
Events
ASBMR 2012
ASBMR 2013
ASBMR 2014
ASBMR 2015
ASMBR 2016
ASMBR 2017
ASMBR 2018
ASMBR 2019
Article in the Journal of Bone and Mineral Research
AlphaStreet interview with CEO Spiros Jamas
Entera presented at ASBMR
Entera Bio Publishes Key Study
Entera presented at ASBMR in Austin Texas
Contact Us
bottom Menu
Sitemap
Accessibility Statement
Please ensure Javascript is enabled for purposes of
website accessibility